DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Kaleido Biosciences Q4 EPS $(0.65) Misses $(0.34) Estimate

Kaleido Biosciences (NASDAQ:KLDO) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.34) by 91.18 percent.

Benzinga · 03/02/2020 12:38

Kaleido Biosciences (NASDAQ:KLDO) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.34) by 91.18 percent.